|
|
|
23 Jul 2008 |
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
|
|
23 Jul 2008 |
Chelsea Therapeutics Granted MHRA Approval to Begin Phase II Trial of Droxidopa in Fibromyalgia
|
|
23 Jul 2008 |
Xanodyne Pharmaceuticals, Inc. Receives Approvable Letter From the U.S. FDA for ZIPSOR(TM) Capsules
|
|
22 Jul 2008 |
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis
|
|
22 Jul 2008 |
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
|
|
22 Jul 2008 |
BioMarin and Summit plc Sign Worldwide Licensing Agreement for Duchenne Muscular Dystrophy Program
|
|
22 Jul 2008 |
Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
|
|
21 Jul 2008 |
Insmed Provides Update on IPLEX(TM) Programs
|
|
21 Jul 2008 |
Targacept Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation Treatment in Major Depressive Disorder
|
|
19 Jul 2008 |
Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
|
|
17 Jul 2008 |
Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Disease
|
|
17 Jul 2008 |
Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
|
|
16 Jul 2008 |
The BRAVO trial, together with the ongoing ALLEGRO trial will investigate oral laquinimod in more than 2,000 RRMS patients worldwide
|
|
16 Jul 2008 |
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
|
|
15 Jul 2008 |
Glenmark’s molecule for Neuropathic Pain, Osteoarthritis - GRC 10693, to enter Phase I trials - GRC 10693 is Glenmark’s fifth molecule to enter clinical trials
|
|
15 Jul 2008 |
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
|
|
14 Jul 2008 |
GlaxoSmithKline and Actelion enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond
|
|
14 Jul 2008 |
Neurogen Announces Suspension of Insomnia Study with Adipiplon
|
|
14 Jul 2008 |
Alkermes Presents Positive Preclinical Data on Naltrexone for Extended-Release Injectable Suspension at Annual Meeting of Controlled Release Society
|
|
13 Jul 2008 |
NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
|
|
10 Jul 2008 |
KeyNeurotek Pharmaceuticals reports breakthrough discovery in Huntington´s Disease
|
|
10 Jul 2008 |
Penwest Begins Phase I Clinical Trial of PW 4153, Candidate For Treatment of Symptoms of Parkinson's Disease
|
|
09 Jul 2008 |
Paion Announces Plan to Commence Clinical Program with its Sedative CNS 7056
|
|
08 Jul 2008 |
Teva Provides Update on FORTE Trial
|
|
08 Jul 2008 |
Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
|
|
08 Jul 2008 |
Sciele Pharma Completes Phase III Safety Trial for Glycopyrrolate Liquid, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients
|
|
08 Jul 2008 |
BrainStorm Cell Therapeutics Inc. Study Positive for Spinal Cord Injuries
|
|
08 Jul 2008 |
Opexa’s Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board
|
|
02 Jul 2008 |
Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
|
|
01 Jul 2008 |
SCOLR Pharma, Inc. Advances Extended-Release Ibuprofen with Initiation of Clinical Study
|
|
30 Jun 2008 |
Headline results of Flurizan(R) in clinical phase III trial
|
|
30 Jun 2008 |
Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
|
|
30 Jun 2008 |
Data Presented at American Headache Society’s Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics’ Tezampanel
|
|
30 Jun 2008 |
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
|
|
30 Jun 2008 |
NuPathe Reports Positive Phase I Results for NP101, a Novel Transdermal Patch for Acute Migraine
|
|
30 Jun 2008 |
Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity
|
|
29 Jun 2008 |
UCB's Vimpat(TM) recommended for approval in Europe for epilepsy
|
|
29 Jun 2008 |
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
|
|
29 Jun 2008 |
FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
|
|
29 Jun 2008 |
Merck's Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study
|
|
29 Jun 2008 |
Orexo report Abstral (Rapinyl) approval in Europe
|
|
29 Jun 2008 |
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
|
|
26 Jun 2008 |
Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the Treatment of Opioid Dependence
|
|
26 Jun 2008 |
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
|
|
26 Jun 2008 |
NeuroSearch successfully completes Phase I with ACR325 and announces the decision to progress development into Phase II Proof-of-Concept studies in Parkinson’s disease and Bipolar Disorder
|
|
22 Jun 2008 |
YM Bioscience Annouces FDA Lifts Clinical Hold on Aerolef(R) and Clearance of a Phase II Clinical Trial
|
|
22 Jun 2008 |
NeuroSearch announces positive key results from a Phase II study with ABT-894 in adults with Attention Deficit-Hyperactivity Disorder (ADHD)
|
|
19 Jun 2008 |
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
|
|
19 Jun 2008 |
Suven Life Sciences Initiates Phase I Clinical Trials in Europe of SUVN-502 for Alzheimer’s disease
|
|
19 Jun 2008 |
Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement
|
| |
|
Results 151 - 200 of 1619 |
